Name | Number of supported studies | Average coverage | |
---|---|---|---|
Mueller cell | 5 studies | 30% ± 18% |
Insufficient scRNA-seq data for expression of NPVF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 31% | 20.52 | 818 / 2642 | 0% | 0.00 | 1 / 705 |
eye | 0% | 0 | 0 / 0 | 30% | 10.93 | 24 / 80 |
spleen | 14% | 0.41 | 34 / 241 | 0% | 0 | 0 / 0 |
skin | 11% | 0.34 | 201 / 1809 | 0% | 0 | 0 / 472 |
uterus | 10% | 0.27 | 17 / 170 | 1% | 0.03 | 3 / 459 |
bladder | 10% | 0.10 | 2 / 21 | 0% | 0 | 0 / 504 |
ovary | 7% | 0.09 | 12 / 180 | 1% | 0.01 | 3 / 430 |
stomach | 5% | 0.07 | 19 / 359 | 1% | 0.01 | 2 / 286 |
prostate | 6% | 0.09 | 14 / 245 | 0% | 0 | 0 / 502 |
breast | 5% | 0.08 | 24 / 459 | 0% | 0.00 | 1 / 1118 |
muscle | 5% | 0.08 | 38 / 803 | 0% | 0 | 0 / 0 |
intestine | 4% | 0.07 | 39 / 966 | 0% | 0.10 | 2 / 527 |
adipose | 4% | 0.06 | 52 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 4% | 0.07 | 54 / 1445 | 1% | 0.01 | 1 / 183 |
adrenal gland | 4% | 0.05 | 11 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 3% | 0.06 | 45 / 1335 | 0% | 0 | 0 / 0 |
kidney | 3% | 0.04 | 3 / 89 | 0% | 0 | 0 / 901 |
heart | 3% | 0.05 | 27 / 861 | 0% | 0 | 0 / 0 |
thymus | 3% | 0.04 | 20 / 653 | 0% | 0 | 0 / 605 |
peripheral blood | 3% | 0.04 | 27 / 929 | 0% | 0 | 0 / 0 |
lung | 2% | 0.03 | 14 / 578 | 0% | 0.00 | 1 / 1155 |
pancreas | 2% | 0.04 | 8 / 328 | 0% | 0 | 0 / 178 |
liver | 2% | 0.02 | 4 / 226 | 0% | 0 | 0 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0032277 | Biological process | negative regulation of gonadotropin secretion |
GO_0005576 | Cellular component | extracellular region |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NPVF |
Protein name | Pro-FMRFamide-related neuropeptide VF [Cleaved into: Neuropeptide NPSF; Neuropeptide RFRP-1; Neuropeptide RFRP-2; Neuropeptide NPVF (Neuropeptide RFRP-3)] |
Synonyms | C7orf9 RFRP |
Description | FUNCTION: Neuropeptide RFRP-1 acts as a potent negative regulator of gonadotropin synthesis and secretion. Neuropeptides NPSF and NPVF efficiently inhibit forskolin-induced production of cAMP, but RFRP-2 shows no inhibitory activity. Neuropeptide RFRP-1 induces secretion of prolactin in rats. Neuropeptide NPVF blocks morphine-induced analgesia. . |
Accessions | Q9HCQ7 ENST00000222674.2 [Q9HCQ7-1] |